FDA Supports Streamlined Trials for New Antimicrobials
September 21st 2018The critical need for new medicines to combat infectious diseases is prompting FDA to join with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to promote innovation in this area.
Simplifying the Implementation of Electronic Patient-Reported Outcomes
September 17th 2018There have been a number of significant scientific and regulatory milestones driving the adoption of electronic patient-reported outcomes in clinical trials since the first screen-based ePRO solution, Minidoc, appeared in 1980.
Recent Trends in Clinical Trials for Coronary Diseases
September 6th 2018In this study, Clinical Trials Transformation Initiative’s database for aggregate analysis of ClinicalTrials.gov was used to evaluate the number of ongoing and completed interventional clinical trials for various coronary diseases.